Inventor · disambiguated record
Carrolee Barlow
Also filed as: BARLOW CARROLEE
6 granted patents·28 pending applications·175 citations·filing 2001–2019
86Inventor score
Files withBRAINCELLS INC25PARKINSONS INST3BARLOW CARROLEE1MITSUBISHI TANABE PHARMA CORP1PARKINSON?S INST1
Top patents by PatentIndex Score
34 records- 0194US7998971B2Combinations containing a 4-acylaminopyridine derivativeBRAINCELLS INC·Filed 2007·Granted Aug 16, 2011·77 cites·5 claims
- 0291US7985756B2Modulation of neurogenesis by PDE inhibitionBRAINCELLS INC·Filed 2006·Granted Jul 26, 2011·35 cites·2 claims
- 0390US7858611B2Neurogenesis by modulating angiotensinBRAINCELLS INC·Filed 2007·Granted Dec 28, 2010·10 cites·2 claims
- 0487US7678808B25 HT receptor mediated neurogenesisBRAINCELLS INC·Filed 2007·Granted Mar 16, 2010·14 cites·3 claims
- 0585US7678363B2Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIsBRAINCELLS INC·Filed 2006·Granted Mar 16, 2010·17 cites·2 claims
- 0682US7510637B2Microelectronic arrays for cell-based functional genomics/high throughput phenotyping by electrokinetic assemblyUNIV CALIFORNIA·Filed 2001·Granted Mar 31, 2009·22 cites·18 claims
- 0760US2010009983A15 ht receptor mediated neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 0859US2010216734A1Modulation of neurogenesis by nootropic agentsBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 0959US2009197823A1Aliskiren modulation of neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1057US2009325949A15 ht receptor mediated neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1156US2008188457A1Modulation of Neurogenesis with Biguanides and GSK3-beta AgentsBRAINCELLS INC·Filed 2008·Application pending·0 cites
- 1256US2008171750A1Modulation Of Neurogenesis With Use of ModafinilBRAINCELLS INC·Filed 2008·Application pending·0 cites
- 1356US2008167363A1Modulation of Neurogenesis By Melatoninergic AgentsBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1455US2008103105A1HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESISBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1555US2008103165A1Ppar mediated modulation of neurogenesisBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1654US2003194711A1System and method for analyzing gene expression dataZAPALA MATTHEW·Filed 2002·Application pending·0 cites
- 1752US2007244143A1Modulation of neurogenesis by nootropic agentsBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1851US2020165358A1Methods and compositions for evaluation and treatment of synucleinopathiesPARKINSON?S INST·Filed 2019·Application pending·0 cites
- 1949US2019358349A1Methods for evaluation of treatment and progression of neurological disordersPARKINSONS INST·Filed 2019·Application pending·0 cites
- 2048US2009239834A1Mcc-257 modulation of neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 2144US2009088449A14-acylaminopyridine derivative mediated neurogenesisMITSUBISHI TANABE PHARMA CORP·Filed 2007·Application pending·0 cites
- 2244US2008108574A1Melanocortin receptor mediated modulation of neurogenesisBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 2342US2007015138A1Methods for identifying agents and conditions that modulate neurogenesisBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 2441US2021047627A1Crispr-based downregulation of alpha-synuclein expression as a novel parkinson's disease therapeuticPARKINSONS INST·Filed 2019·Application pending·0 cites
- 2541US2007112017A1Gaba receptor mediated modulation of neurogenesisBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 2640US2007078083A1MODULATION OF NEUORGENESIS BY HDac INHIBITIONBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 2740US2010184806A1Modulation of neurogenesis by ppar agentsBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 2839US2002133837A1Transgenic animals at a nuclear hormone receptor locusFiled 2001·Application pending·0 cites
- 2937US2010120842A1Neurogenesis by muscarinic receptor modulationBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 3036US2019085394A1Refining diagnosis and treatment of complex multi-symptom neurological disordersPARKINSONS INST·Filed 2016·Application pending·0 cites
- 3136US2011319386A1Neurogenesis by muscarinic receptor modulationBARLOW CARROLEE·Filed 2011·Application pending·0 cites
- 3235US2011269717A1Neurogenesis by modulating angiotensinBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 3333US2011046090A1Modulation of neurogenesis with gaba agents and gaba analogsBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 3432US2010216805A1Modulation of neurogenesis using d-cycloserine combinationsBRAINCELLS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carrolee Barlow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →